GSK has announced a new environmental sustainability goals for both climate and nature, aiming to have a net-zero impact on climate and a net positive impact on nature by 2030.

The new goals form part of GSK’s Trust priority and ESG approach, which support the company’s aim to create long-term value for shareholders and meet the needs of society. Over the next decade, GSK will invest in measures to reduce its environmental impact, in restoration programmes to balance the remaining impact that the company cannot reduce and aim to put back into nature more than the company takes out.

The Science Based Targets Initiative has accredited that GSK’s new carbon targets align to a 1.5 pathway – in line with the most ambitious goal of the Paris Agreement.

Underpinning these goals, the company has set new targets across its different businesses, including: 100 per cent renewable electricity usage and good water stewardship at all GSK sites; 100 per cent of materials sustainably sourced and deforestation free and transitioning to 100 per cent usage of electric vehicles by GSK sales representatives worldwide.

Emma Walmsley, CEO, said, “As a global healthcare company, we want to play our full part in protecting and restoring the planet’s health, in order to protect and improve people’s health. Improving the environmental sustainability of our business also makes us more resilient, protecting our operations, so we can deliver the products that patients and consumers rely on.”

The new goals apply principally to GSK’s Biopharma business and portfolio. The company’s Consumer Healthcare business will also contribute towards these goals through delivery of its own targets, whilst it is part of GSK.

Share Story: